SureTrader SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

SalutWo are people

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
france Member Profile
 
Followed By 0
Posts 31
Boards Moderated 0
Alias Born 12/03/10
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/3/2015 9:13:47 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/12/2015 8:12:12 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/7/2015 11:07:34 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/7/2015 9:17:09 AM
Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China "PR Newswire (US)" - 7/7/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/2/2015 4:36:48 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 7/1/2015 3:12:17 PM
Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study "PR Newswire (US)" - 6/30/2015 9:18:00 AM
Oramed Submits Protocol to U.S. FDA for its Phase IIb Oral Insulin Study "PR Newswire (US)" - 6/30/2015 8:15:00 AM
Oramed Granted Patent in Russia for Oral Administration of GLP-1 "PR Newswire (US)" - 6/16/2015 8:15:00 AM
Oramed Announces Closing of $5.36 Million Registered Direct Offering "PR Newswire (US)" - 6/11/2015 8:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/5/2015 4:48:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/5/2015 1:16:09 PM
Oramed to Raise $5.36 Million in Registered Direct Offering "PR Newswire (US)" - 6/5/2015 8:25:00 AM
Oramed to Present at the American Diabetes Association 75th Scientific Sessions "PR Newswire (US)" - 6/2/2015 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/27/2015 6:05:41 AM
Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study "PR Newswire (US)" - 5/26/2015 8:15:00 AM
Oramed to Present at Upcoming Conferences "PR Newswire (US)" - 5/5/2015 9:25:00 AM
Oramed Pharmaceuticals Rating Reiterated by Zacks (ORMP) "Analyst Ratings Network" - 4/30/2015 5:33:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/28/2015 3:15:59 PM
Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter "PR Newswire (US)" - 4/28/2015 9:25:00 AM
Oramed to Present at the GTC Diabetes Summit "PR Newswire (US)" - 4/20/2015 8:15:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 4/3/2015 8:04:11 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/3/2015 8:02:55 AM
Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin "PR Newswire (US)" - 4/1/2015 10:06:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist